We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA Says State Biosimilars Laws Could Have ‘Chilling Effect’
GPhA Says State Biosimilars Laws Could Have ‘Chilling Effect’
January 29, 2013
Brand drugmakers are pushing states to enact legislation that could create hurdles for biosimilar substitution — a business move designed to hold on to profits, GPhA says.